Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 4Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 66INDUSTRY 8NETWORK 4OTHER_GOV 1NIH 1

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Thoracic 3Genitourinary 2Dermatologic 2Lymphoid 1Head & Neck 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Melanoma 1Lymphoma, Follicular 1Leiomyoma 1Keratosis, Actinic 1Head and Neck Neoplasms 1Constriction, Pathologic 1Arteriovenous Malformations 1

Interventions

pembrolizumab 604Carboplatin 374Paclitaxel 283Cisplatin 270Gemcitabine 252Pemetrexed 194Bevacizumab 191Docetaxel 186Nivolumab 180Injections 169Cyclophosphamide 150atezolizumab 139Fluorouracil 134Capecitabine 133Oxaliplatin 132Dexamethasone 128durvalumab 113Fulvestrant 113130-nm albumin-bound paclitaxel 110fludarabine 103Cetuximab 100Leucovorin 97Rituximab 95venetoclax 90Lenalidomide 83enzalutamide 77Prednisone 77Azacitidine 74Irinotecan 73Doxorubicin 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
INDUSTRY × Therapeutics × 1 year × Clear all
NCT05149755 2026-05-19

Evolutâ„¢ EXPAND TAVR II Pivotal Trial

Medtronic Cardiovascular

Phase NA Active not recruiting
650 enrolled
Lymphoid

Constriction, Pathologic, Lymphoma, Follicular

NCT07581184 2026-05-12

BActinium-1

Aktis Oncology, Inc.

Phase 1 Recruiting
138 enrolled
Genitourinary

Prostatic Neoplasms

NCT07020117 2026-04-21

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Aktis Oncology, Inc.

Phase 1 Recruiting
150 enrolled
BreastHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Triple Negative Breast Neoplasms

NCT07406724 2026-02-12

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Qingdao Sino-Cell Biomedicine Co., Ltd.

Phase 2 Not yet recruiting
90 enrolled
Dermatologic

Melanoma

NCT06448793 2025-12-04

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Bristol-Myers Squibb

Recruiting
55 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04272216 2025-09-09

RAVI Registry

Terumo Medical Corporation

Completed
99 enrolled 15 charts
Genitourinary

Arteriovenous Malformations, Leiomyoma, Prostatic Hyperplasia

NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting
280 enrolled
Dermatologic

Keratosis, Actinic

NCT02392455 2025-07-28

VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC)

Boehringer Ingelheim

Completed
817 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡